This metabolite features a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 somewhere around fifty% with the guardian drug. Plasma concentrations of this metabolite are around forty% of Those people viewed for sildenafil, so that the metabolite accounts for about twenty% of sildenafil's pharmacologic outcomes.Your brows